Literature DB >> 16356583

Natural history and predictors of disease severity in chronic hepatitis C.

Julien Massard1, Vlad Ratziu, Dominique Thabut, Joseph Moussalli, Pascal Lebray, Yves Benhamou, Thierry Poynard.   

Abstract

Cirrhosis is the end-stage consequence of fibrosis progression in patients with chronic hepatitis C. The median time from infection to cirrhosis is 30 years, with a high inter-individual variability, which is now better understood. Several factors have been clearly shown to be associated with fibrosis progression rate: duration of infection, age, male gender, alcohol consumption, HIV co-infection and low CD4 count. Metabolic conditions such as steatosis, being overweight and diabetes are emerging as independent co-factors of fibrogenesis. The recent validation of non-invasive biomarkers should facilitate the study of fibrosis progression in large populations.

Entities:  

Mesh:

Year:  2005        PMID: 16356583     DOI: 10.1016/j.jhep.2005.11.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  51 in total

1.  Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.

Authors:  Maja Jovanović; Branislav Jovanović; Milena Potić; Ljiljana Konstantinović; Miodrag Vrbić; Biljana Radovanović-Dinić; Velimir Kostić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C.

Authors:  Annarosa Cussigh; Edmondo Falleti; Carlo Fabris; Davide Bitetto; Sara Cmet; Elisabetta Fontanini; Sara Bignulin; Ezio Fornasiere; Elisa Fumolo; Rosalba Minisini; Mario Pirisi; Pierluigi Toniutto
Journal:  Immunogenetics       Date:  2010-11-12       Impact factor: 2.846

3.  Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection.

Authors:  Claudia Roeder; Sabine Jordan; Julian Schulze Zur Wiesch; Heike Pfeiffer-Vornkahl; Dietrich Hueppe; Stefan Mauss; Elmar Zehnter; Sabine Stoll; Ulrich Alshuth; Ansgar W Lohse; Stefan Lueth
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.

Authors:  Susanna Naggie
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

Review 5.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

6.  Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Authors:  Yusuke Funaoka; Naoya Sakamoto; Goki Suda; Yasuhiro Itsui; Mina Nakagawa; Sei Kakinuma; Takako Watanabe; Kako Mishima; Mayumi Ueyama; Izumi Onozuka; Sayuri Nitta; Akiko Kitazume; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

7.  Effective use of FibroTest to generate decision trees in hepatitis C.

Authors:  Dana Lau-Corona; Luís Alberto Pineda; Héctor Hugo Avilés; Gabriela Gutiérrez-Reyes; Blanca Eugenia Farfan-Labonne; Rafael Núñez-Nateras; Alan Bonder; Rosalinda Martínez-García; Clara Corona-Lau; Marco Antonio Olivera-Martínez; Maria-Concepción Gutiérrez-Ruiz; Guillermo Robles-Díaz; David Kershenobich
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

Review 9.  Hepatitis C in hemodialysis patients.

Authors:  Smaragdi Marinaki; John N Boletis; Stratigoula Sakellariou; Ioanna K Delladetsima
Journal:  World J Hepatol       Date:  2015-03-27

10.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.